Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
Megadott ok: slow accrual
A legfontosabb adatok
- Hol
- Rochester (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- Mayo Clinic in RochesterRochester, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Mayo Clinic
- Azonosító
- NCT06564051
- A regiszteradat frissítve
- 2026. január 6.
- Eredeti leírás
This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.A teljes eredeti leírásKevesebb
A Prospective Observational Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
This study evaluates the incidence of monoclonal B-cell lymphocytosis MBL) in patients with chronic hepatitis C and to determine if monoclonal b-cell lymphocytosis is affected by treatment for hepatitis C.
Bevonási feltételek: Individuals with chronic hepatitis C who are to begin therapy with DAA; Willing to submit a peripheral blood sample at baseline, end of therapy, 12 weeks after the end of therapy, and 52 weeks from baseline.
Kizáró feltételek: Individuals with chronic hepatitis C who have cirrhosis; Individuals with chronic hepatitis C who have a past history of a lymphoproliferative disorder AND for which they received chemotherapy.